David Ginsberg
AuthID: R-00F-EYD
1
TÃTULO: OnabotulinumtoxinA is Effective in Patients with Urinary Incontinence due to Neurogenic Detrusor Overactivity Regardless of Concomitant Anticholinergic Use or Neurologic Etiology (vol 30, pg 819, 2013) Full Text
AUTORES: Ginsberg, D; Cruz, F ; Herschorn, S; Gousse, A; Keppenne, V; Aliotta, P; Sievert, KD; Brin, MF; Jenkins, B; Thompson, C; Lam, W; Heesakkers, J; Haag Molkenteller, C;
PUBLICAÇÃO: 2014, FONTE: ADVANCES IN THERAPY, VOLUME: 31, NÚMERO: 2
AUTORES: Ginsberg, D; Cruz, F ; Herschorn, S; Gousse, A; Keppenne, V; Aliotta, P; Sievert, KD; Brin, MF; Jenkins, B; Thompson, C; Lam, W; Heesakkers, J; Haag Molkenteller, C;
PUBLICAÇÃO: 2014, FONTE: ADVANCES IN THERAPY, VOLUME: 31, NÚMERO: 2
2
TÃTULO: OnabotulinumtoxinA is Effective in Patients with Urinary Incontinence due to Neurogenic Detrusor Activity Regardless of Concomitant Anticholinergic Use or Neurologic Etiology Full Text
AUTORES: Ginsberg, D; Cruz, F ; Herschorn, S; Gousse, A; Keppenne, V; Aliotta, P; Sievert, KD; Brin, MF; Jenkins, B; Thompson, C; Lam, W; Heesakkers, J; Haag Molkenteller, C;
PUBLICAÇÃO: 2013, FONTE: ADVANCES IN THERAPY, VOLUME: 30, NÚMERO: 9
AUTORES: Ginsberg, D; Cruz, F ; Herschorn, S; Gousse, A; Keppenne, V; Aliotta, P; Sievert, KD; Brin, MF; Jenkins, B; Thompson, C; Lam, W; Heesakkers, J; Haag Molkenteller, C;
PUBLICAÇÃO: 2013, FONTE: ADVANCES IN THERAPY, VOLUME: 30, NÚMERO: 9
